On 4 June 2014, CrossFit uploaded a "parody video to their Facebook page" of Jesus, featuring concepts such as the "Holy Trinity of exercise". Yasmine Hafiz wrote in The Huffington Post that some "viewers are outraged at the disrespectful use of a Christian symbol", with one user asking "on what planet is it comical or encouraged to mock someones belief?"
After the Internet fitness community began talking about an Ohio State University study that described relatively high injury rates among CrossFitters, the Russes mobilized. They had Glassman's father, Jeffrey Glassman (now "chief scientist" at CrossFit), write a comprehensive rebuttal to the study for the CrossFit website. Berger called each and every research subject who had been reported as injured, to conclude that none actually were hurt, and then added an entire stammering Q&A with one of the paper's authors, kinesiology professor Steven Devor. Here's the kicker: The actual subject of the study was the great improvements in fitness the researchers found in CrossFit athletes. Aside from a handful of sentences, it was all positive.
Similarly, any foods that were not easily available to Paleolithic humans are off-limits in this diet, Holley explains. That means processed foods — many of which contain added butter, margarine, and sugar — should not be a part of the paleo diet. The same goes for dairy, which may not have been accessible to Paleolithic humans, and legumes, which many proponents of the diet believe are not easily digestible by the body.
Whole30 is a nutritional program designed to change the way you feel and eat in 30 days. Basically, you have to remove all of the potentially inflammatory foods and beverages in your diet (think: added sugar and sweeteners, alcohol, grains, legumes, dairy, processed foods and beverages, baked goods, and junk foods) and eat three "clean" meals a day, made with Whole30-approved ingredients (think: meats, seafood, veggies, and eggs).
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”